80 related articles for article (PubMed ID: 21636701)
1. Different gene expression profiles in metastasizing midgut carcinoid tumors.
Edfeldt K; Björklund P; Åkerström G; Westin G; Hellman P; Stålberg P
Endocr Relat Cancer; 2011 Aug; 18(4):479-89. PubMed ID: 21636701
[TBL] [Abstract][Full Text] [Related]
2. Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors.
Kidd M; Eick G; Shapiro MD; Camp RL; Mane SM; Modlin IM
Cancer; 2005 Jan; 103(2):229-36. PubMed ID: 15599934
[TBL] [Abstract][Full Text] [Related]
3. Gene expression in midgut carcinoid tumors: potential targets for immunotherapy.
Vikman S; Essand M; Cunningham JL; de la Torre M; Oberg K; Tötterman TH; Giandomenico V
Acta Oncol; 2005; 44(1):32-40. PubMed ID: 15848904
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets.
Capurso G; Lattimore S; Crnogorac-Jurcevic T; Panzuto F; Milione M; Bhakta V; Campanini N; Swift SM; Bordi C; Delle Fave G; Lemoine NR
Endocr Relat Cancer; 2006 Jun; 13(2):541-58. PubMed ID: 16728581
[TBL] [Abstract][Full Text] [Related]
5. Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients.
Feng Y; Sun B; Li X; Zhang L; Niu Y; Xiao C; Ning L; Fang Z; Wang Y; Zhang L; Cheng J; Zhang W; Hao X
Breast Cancer Res Treat; 2007 Jul; 103(3):319-29. PubMed ID: 17123152
[TBL] [Abstract][Full Text] [Related]
6. First report on metastasizing small bowel carcinoids in first-degree relatives in three generations.
Järhult J; Landerholm K; Falkmer S; Nordenskjöld M; Sundler F; Wierup N
Neuroendocrinology; 2010; 91(4):318-23. PubMed ID: 20460879
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
8. The role of genetic markers--NAP1L1, MAGE-D2, and MTA1--in defining small-intestinal carcinoid neoplasia.
Kidd M; Modlin IM; Mane SM; Camp RL; Eick G; Latich I
Ann Surg Oncol; 2006 Feb; 13(2):253-62. PubMed ID: 16424981
[TBL] [Abstract][Full Text] [Related]
9. Common pathogenetic mechanism involving human chromosome 18 in familial and sporadic ileal carcinoid tumors.
Cunningham JL; Díaz de Ståhl T; Sjöblom T; Westin G; Dumanski JP; Janson ET
Genes Chromosomes Cancer; 2011 Feb; 50(2):82-94. PubMed ID: 21104784
[TBL] [Abstract][Full Text] [Related]
10. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
[TBL] [Abstract][Full Text] [Related]
11. Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases.
Hellman P; Lundström T; Ohrvall U; Eriksson B; Skogseid B; Oberg K; Tiensuu Janson E; Akerström G
World J Surg; 2002 Aug; 26(8):991-7. PubMed ID: 12016480
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing key biological pathways between primary breast cancers and their lymph node metastases by gene function-based clustering analysis.
Lähdesmäki H; Hao X; Sun B; Hu L; Yli-Harja O; Shmulevich I; Zhang W
Int J Oncol; 2004 Jun; 24(6):1589-96. PubMed ID: 15138604
[TBL] [Abstract][Full Text] [Related]
13. Genetic background of different cancer cell lines influences the gene set involved in chromosome 8 mediated breast tumor suppression.
Seitz S; Korsching E; Weimer J; Jacobsen A; Arnold N; Meindl A; Arnold W; Gustavus D; Klebig C; Petersen I; Scherneck S
Genes Chromosomes Cancer; 2006 Jun; 45(6):612-27. PubMed ID: 16552773
[TBL] [Abstract][Full Text] [Related]
14. Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
Voland P; Besig S; Rad R; Braun T; Baur DM; Perren A; Langer R; Höfler H; Prinz C
Neuroendocrinology; 2009; 89(1):66-78. PubMed ID: 18708724
[TBL] [Abstract][Full Text] [Related]
15. Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors.
Chaudhry A; Gobl A; Eriksson B; Skogseid B; Oberg K
Cancer Res; 1994 Feb; 54(4):981-6. PubMed ID: 7508823
[TBL] [Abstract][Full Text] [Related]
16. Classification of low-grade neuroendocrine tumors of midgut and unknown origin.
Van Eeden S; Quaedvlieg PF; Taal BG; Offerhaus GJ; Lamers CB; Van Velthuysen ML
Hum Pathol; 2002 Nov; 33(11):1126-32. PubMed ID: 12454818
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer metastases are molecularly distinct from their primary tumors.
Vecchi M; Confalonieri S; Nuciforo P; Viganò MA; Capra M; Bianchi M; Nicosia D; Bianchi F; Galimberti V; Viale G; Palermo G; Riccardi A; Campanini R; Daidone MG; Pierotti MA; Pece S; Di Fiore PP
Oncogene; 2008 Apr; 27(15):2148-58. PubMed ID: 17952122
[TBL] [Abstract][Full Text] [Related]
18. Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3.
Schaefer KL; Brachwitz K; Wai DH; Braun Y; Diallo R; Korsching E; Eisenacher M; Voss R; Van Valen F; Baer C; Selle B; Spahn L; Liao SK; Lee KA; Hogendoorn PC; Reifenberger G; Gabbert HE; Poremba C
Cancer Res; 2004 May; 64(10):3395-405. PubMed ID: 15150091
[TBL] [Abstract][Full Text] [Related]
19. Exon-based clustering of murine breast tumor transcriptomes reveals alternative exons whose expression is associated with metastasis.
Dutertre M; Lacroix-Triki M; Driouch K; de la Grange P; Gratadou L; Beck S; Millevoi S; Tazi J; Lidereau R; Vagner S; Auboeuf D
Cancer Res; 2010 Feb; 70(3):896-905. PubMed ID: 20103641
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
